MYLAN 5220 Pill - pink capsule/oblong, 18mm
Generic Name: diltiazem
Pill with imprint MYLAN 5220 is Pink, Capsule/Oblong and has been identified as Diltiazem Hydrochloride Extended-Release (XR) 120 mg. It is supplied by Mylan Pharmaceuticals Inc.
Diltiazem Hydrochloride XR is used in the treatment of Heart Failure; High Blood Pressure; Angina Pectoris Prophylaxis and belongs to the drug classes calcium channel blockers, group IV antiarrhythmics. Risk cannot be ruled out during pregnancy. Diltiazem Hydrochloride XR 120 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for MYLAN 5220




Diltiazem Hydrochloride Extended-Release (XR)
- Generic Name
- diltiazem
- Imprint
- MYLAN 5220
- Strength
- 120 mg
- Color
- Pink
- Size
- 18.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Calcium channel blockers, Group IV antiarrhythmics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients
-
ammonia,
dibutyl sebacate,
magnesium stearate,
maltodextrin,
microcrystalline cellulose,
oleic acid,
silicon dioxide,
sodium lauryl sulfate,
FD&C Blue No. 1,
FD&C Red No. 40,
titanium dioxide,
D&C Red No. 28,
ferrosoferric oxide,
D&C Yellow No. 10,
FD&C Blue No. 2,
propylene glycol,
shellac
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
00378-5220 (Discontinued) | Mylan Pharmaceuticals Inc. |
51079-0947 (Discontinued) | UDL Laboratories Inc. |
More about Diltiazem Hydrochloride XR (diltiazem)
- Check interactions
- Compare alternatives
- Reviews (2)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: calcium channel blockers
- Breastfeeding
Patient resources
Other brands
Cardizem, Cartia XT, Dilt-XR, Tiazac, ... +5 more
Professional resources
Other brands
Cardizem, Cartia XT, Dilt-XR, Cardizem CD, ... +6 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.